School of Medicine
Showing 3,301-3,400 of 4,416 Results
-
Daniela Rodriguez Martinez
Assistant Manager, Communications, School of Medicine - MDRP'S - Biodesign Program
Current Role at StanfordAssistant Manager, Communications @Stanford Byers Center for Biodesign
-
Morteza Roodgar DVM, PhD
Veterinarian Research Scientist, Genetics
BioDr. Morteza Roodgar is a veterinarian scientist with a research focus on Primate induced Pluripotent Stem Cells (iPSCs) and long-read genomics tools.
Dr. Roodgar's research focus is on primate stem cell biology, immunology, and comparative genomics of nonhuman primate models for human diseases. The long-term goal of Dr. Roodgar's research is to Replace, Reduce and Refine (aka 3 R’s) the use of animals in biomedical research leveraging primate induced pluripotent stem cells (iPSCs) and long-read genomic tools to speed up preclinical testing.
Previous research includes immunology and genomic susceptibility to infectious diseases (e.g., tuberculosis, TB) in nonhuman primate models, Preventive Veterinary Medicine and emerging zoonotic diseases (e.g., COVID-19 and Monkeypox). -
Michal Bental Roof
Academic Prog Prof 3, Pediatrics - Cardiology
Current Role at StanfordI joined the Cardiopulmonary Research Program of Drs. Rabinovitch and Bland at Stanford University in 2002, as the Academic and Research Program Officer, and since 2020 assumed my role at the Basic Science and Engineering (BASE) Initiative at the Betty Irene Moore Children's Heart Center, directed by Dr. Rabinovitch. I organize the educational activities of the lab, and assist the faculty and fellows with the preparation of grant proposals, IRB, APLAC and Biosafety protocols, manuscripts, and presentations. I served as the Site Coordinator for the Stanford Transplant Procurement Center of the Pulmonary Hypertension Breakthrough Initiative (PHBI), headed by Dr. Rabinovitch,that now evolved into the Stanford Transplant Tissue Bank. In this capacity, I oversee patient recruitment, data collection and reporting, and ensure compliance with university and federal guidelines. I coordinated and prepared the application for an Investigational New Drug (IND) and the pre-IND meeting that preceded that, for Elafin as a therapy for pulmonary arterial hypertension (PAH) to the FDA in August 2017, and with the Study PIs coordinated the Phase 1 clinical trial “Safety and Tolerability of Escalating Doses of Subcutaneous Elafin (Tiprelestat) Injection in Healthy Normal Subjects” that followed.
From 2005-2015, I served as the Administrative Coordinator of the Cardiovascular and Pulmonary Science Scholarly Concentration for medical students at Stanford University School of Medicine. This includes facilitating communication of the four co-Directors with the School of Medicine Administration, the medical students, and the faculty mentors. An important component of this role is the coordination of the MED223 course, a medical school course where faculty and fellows present new developments in cardiovascular science in the form of a journal club. From 2013-2018, I was the coordinator for the NIH-NHLBI T32 “Mechanisms and Innovation in Vascular Disease” (PI: RL Dalman), and from 2013 to date for NIH-NHLBI K12 HL120001 “Stanford Career Development Program in ‘Omics’ of Lung Disease”. (PIs: M Rabinovitch, MR Nicolls and MP Snyder). This included recruitment of candidates, oversight of training activities, ensuring compliance with NIH and Stanford policies, and acting as a liaison between the trainees and the Directors to facilitate effective communication.
Prior to joining Stanford, I was Associate Director (Scientific Development Administrator) at the Institute for Medicine and Engineering, directed by Dr. Peter Davies at the University of Pennsylvania. In this role, I was the liaison with federal funding agencies and organized multi-investigator program projects and training grants. -
Allyson Rosen, Ph.D., ABPP-CN
Clinical Professor (Affiliated), Psych/Public Mental Health & Population Sciences
Staff, Psychiatry and Behavioral SciencesBioRESEARCH FOCUS
Translational cognitive neuroscience of aging and dementia. Neuroethics.
TRAINING
Dr. Rosen is board certified in clinical neuropsychology with a geriatric focus. She completed college at Brown University, a clinical psychology Ph.D. from Case Western Reserve University, clinical neuropsychology internship at the Long Island Jewish Hospital in New York, and clinical neuropsychology postdoctoral fellowship at the Medical College of Wisconsin. Dr. Rosen completed specialty research fellowship training at the National Institute on Aging (Intramural Research Training Award) and Stanford (NRSA F32, K01) in functional imaging and noninvasive brain stimulation with support from NIA.
CLINICAL AND RESEARCH ACTIVITIES
Dr. Rosen is Director of Dementia Education at the Mental Illness Research Education and Clinical Center at the Palo Alto VAHCS. She is also a neuropsychologist and part of the consensus clinical group and education core at the Stanford’s Alzheimer’s Disease Research Center (NIA). Dr. Rosen’s funded research has focused on applying cognitive neuroscience of aging to improve clinical practice in older adults by using cognitive measures, brain imaging, and noninvasive brain stimulation such as TMS. Studies include using fMRI as an outcome measure for cognitive training, studying how to improve the accuracy of transcranial magnetic stimulation targeting with and without image guidance, and using structural MRI to avoid postoperative cognitive decline and improve outcome from carotid vascular procedures. She has a longstanding commitment to neuroethics and leads a feature in the Journal of Alzheimer Disease that focuses on ethical issues in new and emerging AD applications.
ETHICS EDITOR, JOURNAL OF ALZHEIMER'S DISEASE
Ethics Review
http://www.j-alz.com/blogs/discussion/protecting-progress
MIRECC DEMENTIA EDUCATION
http://www.mirecc.va.gov/visn21/education/dementia_education.asp -
Maryam Rostami
Professional-NX, Psychiatry and Behavioral Sciences
BioMaryam Rostami is a professional data analyst in the Department of Psychiatry and Behavioral Science at Stanford university, currently working in the area of neuroethics and public health. She got a PhD in cognitive neuroscience and neuroimaging from Tohoku university/Japan that folloed by two years of research in the same area at Stanford university.
-
Charlene Larson Rotandi
Associate Director of Fellowship Education, Pediatrics
BioI am the Associate Director of Fellowship Education in the Office of Pediatric Education. I have extensive experience managing fellowship and residency programs across leading academic institutions, including pediatric and graduate medical education roles. My background has equipped me with strong program administration, coordination, and leadership skills within medical education.
I am actively involved in the Association of Pediatric Program Directors (APPD) and currently serve on the Communications Work Group for the Coordinators’ Executive Committee. I have a strong track record of collaborating on initiatives focused on professional development, coordinator wellness, and program evaluation. My experience includes leading workshops and contributing to key areas such as curriculum development, assessment, and program coordinator professional development. Additionally, I am passionate about mentoring and continuously seek opportunities to collaborate and support others in the field.
Outside of graduate medical education, I am the mother of a very active and curious twelve-year-old. I also enjoy spending time with my family exploring the Bay Area, hiking, cooking, and enjoying food, wine, and the vibrant arts culture. After a brief stint as a pastry cook, I love to cook and bake with my son. Additionally, I continue to be involved in my alma mater, Vassar College, by co-chairing the Vassar Alumnae/i Admissions Program in San Francisco. -
Raheleh Roudi
Basic Life Research Scientist, Rad/Pediatric Radiology
BioRaheleh Roudi is a research scientist in the Department of Radiology at Stanford University. Dr. Roudi trained at the Iran University of Medical Sciences, Iran. She worked as an Assistant Professor at the Iran University of Medical Sciences, Iran from 2015 to 2019, before coming to the United States. During this time, Dr. Roudi worked on several projects which have led to successful collaborations with the Karolinska Institute; Charite Universitatsmedizin Berlin; Oslo University Hospital; National University of Singapore; Shanghai University of Traditional Chinese Medicine and University of Brescia, among other internationally recognized institutions.
Dr. Roudi was a visiting scientist in the University of Texas at San Antonio and then appointed as a postdoctoral associate at the University of Minnesota for one year, before joining Stanford University in 2022.
Her research interest focuses on the molecular oncology and immunotherapies of solid tumors and she published more than 40 peer reviewed papers. -
Larissa Roux MD PhD
Adjunct Professor, Medicine - Primary Care and Population Health
BioLarissa Roux is a sport medicine physician and health economist. She completed medical school at the University of Alberta, and followed this with residency training in family medicine and a fellowship in primary care sport medicine at the University of Calgary, as well as advanced training in lifestyle medicine. She combined her clinical training with a master’s in public health at Harvard, and a PhD in health economics at the University of Calgary. Her interest in public health and health policy resulted in a post-doctoral fellowship at the US Centers for Disease Control, in Atlanta in the Division of Nutrition and Physical Activity. Although she has deeply enjoyed working with athletes and dancers, her main clinical interest has been in the optimization of human performance in patients with chronic conditions, including obesity, arthritis, and trauma. Her academic and health policy work has focused on the economic evaluation of competing therapies for obesity, and population-level physical activity promotion strategies in the US and around the world. Larissa's interest in data science and technology applications in global health contributed to an ongoing health information technology venture. She believes that innovative, tailored, multidisciplinary, and multimodal approaches to chronic disease have transformative potential in human health.
-
Michael Rubin
Adjunct Professor, Medicine
BioMichael P. Rubin, MD, PhD is the Founder and CEO of Northpond Ventures, a multi-billion dollar science driven venture capital firm. Northpond is based in Cambridge, MA; San Francisco, CA; and Bethesda, MD. Dr. Rubin has been involved in investing in and developing over 100 startups, in a broad array of disciplines, including medicine, technology, financial services, and global consumer. Dr. Rubin’s experience spans engineering, medicine, surgery, venture capital, and entrepreneurship. Dr. Rubin also holds academic appointments at Harvard and MIT.
-
Erica Marie Rutherford
Data Wrangler, Biomedical Data Science
BioMy career spanning nine years as a data curator has given me a lot of experience and perspective into the workings of scientific data and metadata, and its organization. During my time before graduate school, I attained experience on a variety of fieldwork projects in ecology (2008-2013). During these temporary seasonal assignments, the importance of precision and care in data collection was impressed in me. When I went to graduate school at San Francisco State University (2013-2016), I gained experience in all parts of a molecular biology experiment, from fieldwork to labwork to data analysis. After graduation, I worked at a microbiome focused startup company, Second Genome, as their data curator (2016-2021). While there, I was responsible for curation of metadata for both internal studies for R&D and for clients, and for external studies being brought in for our internal Knowledgebase. While there, I developed an appreciate for ontologies, and developed a custom Second Genome Ontology to handle our metadata. I moved on to the Lattice group, located at Stanford University, where I continued to expand my skills in data curation (2021-present). I have gained experience in handling single cell datasets and their associated metadata, and curating them to meet precise standards. I strive to work collaboratively with data contributors in order to ensure FAIR data standards.
-
Suzanne Michelle Sachsman, MD
Basic Life Research Scientist, Dermatology
BioSuzanne Sachsman, M.D., is Clinical Assistant Professor of Dermatology. Dr. Sachsman received her Bachelor of Science degree in engineering from Brown University in 2000. She received her medical degree from the Keck School of Medicine of the University of Southern California in 2008 where she spent one year doing dedicated basic science research studying cancer immunotherapy. She trained in radiation oncology, completing residency at USC and fellowship at the University of Florida Health Proton Therapy Institute, prior to completing her dermatology residency at the University of California, Los Angeles in 2018. Dr. Sachsman is a board certified dermatologist and Fellow of the American Academy of Dermatology. Her clinical interests are general dermatology and complex medical dermatology including acne, psoriasis, atopic dermatitis, high risk non-melanoma skin cancer, pigmented lesions, supportive dermato-oncology, and cutaneous lymphoma.
-
Jeffrey Sagun
Assistant Clinical Research Coordinator, Dermatology
BioJeffrey Sagun, B.S., is a REACH Postbaccalaureate Scholar at Stanford Medicine's Department of Dermatology. He was born and raised in Chicago. He received his B.S. in Neuroscience from Trinity College–Hartford in 2021 and was a Posse Foundation Scholar. He then spent three years training at the NIH/NCI as a NIH Academy Enrichment Program Scholar and Postbac CRTA Research Fellow, studying neurological disease in xeroderma pigmentosum patients. He is currently interested in studying the clinical characteristics and genetic causes of rare or complex disease patients.
-
Mustafa Caglar Sahin
Visiting Instructor, Neurosurgery
BioMustafa Caglar Sahin, MD is a neurosurgeon and research scholar at Stanford University with a primary focus on neuro-oncology and stereotactic radiosurgery. He completed his medical education at Erciyes University and his neurosurgical residency at Gazi University. Following his residency training, he has worked as a board-certified neurosurgeon, gaining independent clinical experience in the management of intracranial tumors and complex cranial pathologies.
Dr. Sahin’s clinical practice includes the treatment of meningiomas, vestibular schwannomas, pituitary adenomas, gliomas, and other intracranial tumors. He has experience in microsurgical tumor resection, multimodal treatment planning, and stereotactic radiosurgery applications. His work also involves outcome evaluation and longitudinal patient follow-up in neuro-oncology.
In parallel with his clinical career, Dr. Sahin has developed an active research portfolio integrating clinical neurosurgery with molecular tumor biology and computational approaches. A central focus of his research has been telomere biology and long non-coding RNA regulation in meningiomas, particularly investigating the role of TERRA expression and telomere dynamics as potential biomarkers for tumor monitoring and prognosis. His work in this field has been recognized with the Best Young Meningioma Researcher Award.
He has also contributed to research exploring artificial intelligence applications in neurosurgery, including studies evaluating large language models in neurosurgical education and comparative analyses of AI systems in brain MRI interpretation. Through his academic work, he aims to contribute to the development of data-informed, evidence-based strategies for improving clinical decision-making in patients with intracranial tumors.
Dr. Sahin is a member of the European Association of Neurosurgical Societies, the European Skull Base Society, and the Turkish Neurosurgical Association. His long-term vision is to bridge surgical precision with computational intelligence and translational tumor biology to improve evidence-based decision-making in neuro-oncology. -
Hamed Sajjadi, MD, FACS
Staff, OHNS/Otolaryngology/Head & Neck Surgery
Clinical Professor (Affiliated), OHNS/Otology & Neurotology DivisionCurrent Role at StanfordClinical Professor, supervising residents and medical students at Palo Alto VA health care system on a weekly basis.
-
Sara Saki
Clinical Research Coordinator, Adult Neurology
Current Role at StanfordClinical Research Coordinator at Stroke Center
